Leishmania mexicana amastigotes inhibit p38 and JNK and activate PI3K/AKT: Role in the inhibition of apoptosis of dendritic cells

Parasite Immunology

Volumn 37, Issue 11, 2015, Pages 579-589

  Vazquez Lopez R ^a   Argueta Donohue J ^b   Wilkins Rodriguez A ^b   Escalona Montano A ^b   Aguirre Garcia M ^b   Gutierrez Kobeh L ^b  

^a UNIVERSIDAD ANÁHUAC   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amastigotes; Apoptosis; Dendritic cells; Leishmania mexicana; Mitogen activated protein kinase; PI3K

Indexed keywords

CAMPTOTHECIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE 1;

AMASTIGOTE; ANIMAL CELL; APOPTOSIS; ARTICLE; DENDRITIC CELL; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; LEISHMANIA MEXICANA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SKIN LEISHMANIASIS; ADULT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LEISHMANIASIS; MALE; METABOLISM; PARASITOLOGY; PATHOLOGY; PHOSPHORYLATION; YOUNG ADULT;

ADULT; APOPTOSIS; CAMPTOTHECIN; DENDRITIC CELLS; HUMANS; LEISHMANIA MEXICANA; LEISHMANIASIS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 8; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; YOUNG ADULT;

EID: 84945137881     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12275     Document Type: Article

References (59)

1. Solbach W & Laskay T. The host response to Leishmania infection. Adv Immunol 2000; 74: 275-317.
2. Kane MM & Mosser DM. Leishmania parasites and their ploys to disrupt macrophage activation. Curr Opin Hematol 2000; 7: 26-31.
3. Rittig MG & Bogdan C. Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 2000; 16: 292-297.
4. Verma G & Datta M. The critical role of JNK in the ER-mitochondrial crosstalk during apoptotic cell death. J Cell Physiol 2012; 227: 1791-1795.
5. Hoeflich KP, Yeh WC, Yao Z, Mak TW & Woodgett JR. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 1999; 18: 5814-5820.
6. Kyriakis JM & Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-869.
7. Luo HR, Hattori H, Hossain MA, et al. Akt as a mediator of cell death. Proc Natl Acad Sci USA 2003; 100: 11712-11717.
8. Macdonald NJ, Delderfield SM, Zhang W & Taglialatela G. Tumour necrosis factor-alpha- vs. growth factor deprivation-promoted cell death: distinct converging pathways. Aging Cell 2003; 2: 245-256.
9. Tran TH, Andreka P, Rodrigues CO, Webster KA & Bishopric NH. Jun kinase delays caspase-9 activation by interaction with the apoptosome. J Biol Chem 2007; 282: 20340-20350.
10. Hommes DW, Peppelenbosch MP & van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003; 52: 144-151.
11. Schaeffer HJ & Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19: 2435-2444.
12. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 2000; 12: 186-192.
13. Sui X, Kong N, Ye L, et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett 2014; 344: 174-179.
14. Cuadrado A & Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J 2010; 429: 403-417.
15. Sabapathy K. Role of the JNK pathway in human diseases. Prog Mol Biol Transl Sci 2012; 106: 145-169.
16. Vivanco I & Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2: 489-501.
17. Barry M & Bleackley RC. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2002; 2: 401-409.
18. Roulston A, Marcellus RC & Branton PE. Viruses and apoptosis. Annu Rev Microbiol 1999; 53: 577-628.
19. Gao LY & Kwaik YA. The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol 2000; 8: 306-313.
20. Sinai AP, Payne TM, Carmen JC, Hardi L, Watson SJ & Molestina RE. Mechanisms underlying the manipulation of host apoptotic pathways by Toxoplasma gondii. Int J Parasitol 2004; 34: 381-391.
21. Schaumburg F, Hippe D, Vutova P & Luder CG. Pro- and anti-apoptotic activities of protozoan parasites. Parasitology 2006; 132(Suppl): S69-S85.
22. Akarid K, Arnoult D, Micic-Polianski J, Sif J, Estaquier J & Ameisen JC. Leishmania major-mediated prevention of programmed cell death induction in infected macrophages is associated with the repression of mitochondrial release of cytochrome c. J Leukoc Biol 2004; 76: 95-103.
23. Moore KJ & Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 1994; 152: 2930-2937.
24. Moore KJ, Turco SJ & Matlashewski G. Leishmania donovani infection enhances macrophage viability in the absence of exogenous growth factor. J Leukoc Biol 1994; 55: 91-98.
25. Lisi S, Sisto M, Acquafredda A, et al. Infection with Leishmania infantum Inhibits actinomycin D-induced apoptosis of human monocytic cell line U-937. J Eukaryot Microbiol 2005; 52: 211-217.
26. Aga E, Katschinski DM, van Zandbergen G, et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 2002; 169: 898-905.
27. Valdes-Reyes L, Argueta J, Moran J, et al. Leishmania mexicana: inhibition of camptothecin-induced apoptosis of monocyte-derived dendritic cells. Exp Parasitol 2009; 121: 199-207.
28. Gutierrez-Kobeh L, de Oyarzabal E, Argueta J, et al. Inhibition of dendritic cell apoptosis by Leishmania mexicana amastigotes. Parasitol Res 2013; 112: 1755-1762.
29. Ruhland A, Leal N & Kima PE. Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. Cell Microbiol 2007; 9: 84-96.
30. Sarkar A, Aga E, Bussmeyer U, et al. Infection of neutrophil granulocytes with Leishmania major activates ERK 1/2 and modulates multiple apoptotic pathways to inhibit apoptosis. Med Microbiol Immunol 2013; 202: 25-35.
31. Agallou M, Dotsika E, Frydas S & Karagouni E. Toll-like receptor 4 promotes control of Leishmania infantum infection through inducement of leishmanicidal activity in host macrophages: role of mitogen activated kinases. J Biol Regul Homeost Agents 2014; 28: 41-52.
32. Boggiatto PM, Martinez PA, Pullikuth A, et al. Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold. Microb Infect 2014; 16: 328-336.
33. Ruhland A & Kima PE. Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp Parasitol 2009; 122: 28-36.
34. Handley ME, Thakker M, Pollara G, Chain BM & Katz DR. JNK activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis. Free Radic Biol Med 2005; 38: 1637-1652.
35. Xie J, Qian J, Yang J, Wang S, Freeman ME 3rd & Yi Q. Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells. Exp Hematol 2005; 33: 564-572.
36. Nakagawa S, Ohtani T, Mizuashi M, et al. p38 Mitogen-Activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells. J Invest Dermatol 2004; 123: 361-370.
37. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83-93.
38. Sallusto F & Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-1118.
39. Donovan MJ, Maciuba BZ, Mahan CE & McDowell MA. Leishmania infection inhibits cycloheximide-induced macrophage apoptosis in a strain-dependent manner. Exp Parasitol 2009; 123: 58-64.
40. Hart DT, Vickerman K & Coombs GH. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology 1981; 82: 345-355.
41. Mosser DM & Edelson PJ. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J Immunol 1985; 135: 2785-2789.
42. Yang Z, Mosser DM & Zhang X. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol 2007; 178: 1077-1085.
43. Bates PA, Robertson CD, Tetley L & Coombs GH. Axenic cultivation and characterization of Leishmania mexicana amastigote-like forms. Parasitology 1992; 105(Pt 2): 193-202.
44. Wilkins-Rodriguez AA, Escalona-Montano AR, Aguirre-Garcia M, Becker I & Gutierrez-Kobeh L. Regulation of the expression of nitric oxide synthase by Leishmania mexicana amastigotes in murine dendritic cells. Exp Parasitol 2010; 126: 426-434.
45. Blank C, Fuchs H, Rappersberger K, Rollinghoff M & Moll H. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J Infect Dis 1993; 167: 418-425.
46. Morris EJ & Geller HM. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol 1996; 134: 757-770.
47. Gorczyca W, Gong J & Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53: 1945-1951.
48. Sanders EJ & Wride MA. Ultrastructural identification of apoptotic nuclei using the TUNEL technique. Histochem J 1996; 28: 275-281.
49. Junghae M & Raynes JG. Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infect Immun 2002; 70: 5026-5035.
50. Awasthi A, Mathur R, Khan A, et al. CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response. J Exp Med 2003; 197: 1037-1043.
51. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B & Saha B. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 2004; 10: 540-544.
52. Prive C & Descoteaux A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur J Immunol 2000; 30: 2235-2244.
53. Ghosh S, Bhattacharyya S, Sirkar M, et al. Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect Immun 2002; 70: 6828-6838.
54. Chandra D & Naik S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin Exp Immunol 2008; 154: 224-234.
55. Mookerjee Basu J, Mookerjee A, Sen P, et al. Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother 2006; 50: 1788-1797.
56. Saha P, Bhattacharjee S, Sarkar A, Manna A, Majumder S & Chatterjee M. Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages. PLoS ONE 2011; 6: e18467.
57. Shweash M, Adrienne McGachy H, Schroeder J, et al. Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression. Mol Immunol 2011; 48: 1800-1808.
58. Chen YR & Tan TH. The c-Jun N-terminal kinase pathway and apoptotic signaling (review). Int J Oncol 2000; 16: 651-662.
59. Sims JT, Ganguly S, Fiore LS, Holler CJ, Park ES & Plattner R. STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner. Biochem Pharmacol 2009; 78: 249-260.